Crossmark

Histological findings after argon plasma coagulation: an ex-vivo study revealing a possible role in superficial ablative treatment of the skin

Crossref DOI link: https://doi.org/10.1007/s00403-018-1810-3

Published Online: 2018-01-19

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmitz, L.

Hessam, S.

Scholl, L.

Reitenbach, S.

Segert, M. H.

Gambichler, T.

Stockfleth, E.

Bechara, F. G.
License Information

Text and Data Mining valid from 2018-01-19
More Information

Article History

Received: 22 August 2017

Revised: 9 January 2018

Accepted: 12 January 2018

First Online: 19 January 2018

Compliance with ethical standards

:

: L. Schmitz: lecture fees from Almirall, Biofrontera, Galderma, Meda, and Riemser. S. Hessam: none. L. Scholl: none. S. Reitenbach: none. M.H. Segert: none. T. Gambichler: lecture fees from Novartis, Roche, NeraCare, and BMS. E. Stockfleth: lectures from Almirall, Leo, and Pierre Fabre. FG Bechara: none.

: Obtained (No.: #15-5524-BR).

: Obtained from all study subjects.